Viewing data from:

LIOTHYRONINE SODIUM

ANDA

LIOTHYRONINE SODIUM | A214803 | ZYDUS LIFESCIENCES GLOBAL FZE

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CYTOMEL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$0.3615

per ea

Lowest NADAC/Unit

$0.2283

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
16714016801LIOTHYRONINE SOD 50 MCG TAB	$0.3615	EA	Generic	—	2026-06-17
68382058401LIOTHYRONINE SOD 50 MCG TAB	$0.3615	EA	Generic	—	2026-06-17
16714016701LIOTHYRONINE SOD 25 MCG TAB	$0.3191	EA	Generic	—	2026-06-17
68382058301LIOTHYRONINE SOD 25 MCG TAB	$0.3191	EA	Generic	—	2026-06-17
16714016601LIOTHYRONINE SOD 5 MCG TAB	$0.2283	EA	Generic	—	2026-06-17
68382058201LIOTHYRONINE SOD 5 MCG TAB	$0.2283	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

PEPTIDO GMBHLIOTHYRONINE SODIUM

DMF 194672006

AZICO BIOPHORE INDIA PVT LTDLIOTHYRONINE SODIUM

DMF 309422016

VALARY LAB PRIVATE LIMITEDLIOTHYRONINE SODIUM

DMF 389032023

MACLEODS PHARMACEUTICALS LTDLIOTHYRONINE SODIUM USP

DMF 424012025

SANDOZ GMBHInactiveLIOTHYRONINE SODIUM

DMF 71101987

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 0.005MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 22, 2021

No patent or exclusivity listings for this strength.

#002 — EQ 0.025MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 22, 2021

#003 — EQ 0.05MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 22, 2021